Role of Disulfide Cross-Linking of Mutant SOD1 in the Formation of Inclusion-Body-Like Structures

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Roberts, Brittany L T ^a   Patel, Kinaree ^a   Brown, Hilda H ^a   Borchelt, David R ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; COPPER ZINC SUPEROXIDE DISMUTASE; CYSTEINE; CYTOSINE; DISULFIDE; GLYCINE; GUANINE; HYBRID PROTEIN; MUTANT PROTEIN; PHENYLALANINE; SERINE; TYROSINE; YELLOW FLUORESCENT PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ARTICLE; CELL INCLUSION; CELL STRUCTURE; CONTROLLED STUDY; DISULFIDE BOND; MUTATION; MUTATIONAL ANALYSIS; NONHUMAN; PROTEIN AGGREGATION; PROTEIN CROSS LINKING;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BACTERIAL PROTEINS; CHO CELLS; CRICETINAE; CROSS-LINKING REAGENTS; CYSTEINE; DISEASE MODELS, ANIMAL; DISULFIDES; HUMANS; INCLUSION BODIES; LUMINESCENT PROTEINS; MUTATION; PROTEIN FOLDING; SUPEROXIDE DISMUTASE;

EID: 84868275877     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047838     Document Type: Article

References (45)

1. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62.
2. Parge HE, Hallewell RA, Tainer JA, (1992) Atomic structures of wild- type and thermostable mutant recombinant human Cu,Zn superoxide dismutase. Proc Natl Acad Sci USA 89: 6109-6113.
3. Ogihara NL, Parge HE, Hart PJ, Weiss MS, Goto JJ, et al. (1996) Unusual trigonal-planar copper configuration revealed in the atomic structure of yeast copper-zinc superoxide dismutase. Biochemistry 35: 2316-2321.
4. Borchelt DR, Lee MK, Slunt HH, Guarnieri M, Xu Z-S, et al. (1994) Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci USA 91: 8292-8296.
5. Potter SZ, Valentine JS, (2003) The perplexing role of copper-zinc superoxide dismutase in amyotrophic lateral sclerosis (Lou Gehrig's disease). J Biol Inorg Chem 8: 373-380.
6. Valentine JS, Hart PJ, (2003) Misfolded CuZnSOD and amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 100: 3617-3622.
7. Nishida CR, Butler Gralla E, Selverstone Valentine J, (1994) Characterization of three yeast copper-zinc superoxide dismutase mutants analogous to those coded for in familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 91: 9906-9910.
8. Ratovitski T, Corson LB, Strain J, Wong P, Cleveland DW, et al. (1999) Variation in the biochemical/biophysical properties of mutant superoxide dismutase 1 enzymes and the rate of disease progression in familial amyotrophic lateral sclerosis kindreds. Hum Mol Genet 8: 1451-1460.
9. Wiedau-Pazos M, Goto JJ, Rabizadeh S, Gralla EB, Roe JA, et al. (1996) Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271: 515-518.
10. Hayward LJ, Rodriguez JA, Kim JW, Tiwari A, Goto JJ, et al. (2002) Decreased Metallation and Activity in Subsets of Mutant Superoxide Dismutases Associated with Familial Amyotrophic Lateral Sclerosis. J Biol Chem 277: 15923-15931.
11. Jonsson PA, Ernhill K, Andersen PM, Bergemalm D, Brannstrom T, et al. (2004) Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis. Brain 127: 73-88.
12. Wang J, Xu G, Li H, Gonzales V, Fromholt D, et al. (2005) Somatodendritic accumulation of misfolded SOD1-L126Z in motor neurons mediates degeneration: {alpha}B-crystallin modulates aggregation. Hum Mol Genet 14: 2335-2347.
13. Wang J, Caruano-Yzermans A, Rodriguez A, Scheurmann JP, Slunt HH, et al. (2007) Disease-associated mutations at copper ligand histidine residues of superoxide dismutase 1 diminish the binding of copper and compromise dimer stability. J Biol Chem 282: 345-352.
14. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, et al. (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264: 1772-1775.
15. Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, et al. (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14: 1105-1116.
16. Jonsson PA, Graffmo KS, Brannstrom T, Nilsson P, Andersen PM, et al. (2006) Motor neuron disease in mice expressing the wild type-like D90A mutant superoxide dismutase-1. J Neuropathol Exp Neurol 65: 1126-1136.
17. Reaume AG, Elliott JL, Hoffman EK, Kowall NW, Ferrante RJ, et al. (1996) Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nature Genetics 13: 43-47.
18. Johnston JA, Dalton MJ, Gurney ME, Kopito RR, (2000) Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 97: 12571-12576.
19. Shinder GA, Lacourse MC, Minotti S, Durham HD, (2001) Mutant Cu/Zn-superoxide dismutase proteins have altered solubility and interact with heat shock/stress proteins in models of amyotrophic lateral sclerosis. J Biol Chem 276: 12791-12796.
20. Wang J, Xu G, Borchelt DR, (2002) High molecular weight complexes of mutant superoxide dismutase 1: age- dependent and tissue-specific accumulation. Neurobiol Dis 9: 139-148.
21. Wang J, Xu G, Gonzales V, Coonfield M, Fromholt D, et al. (2002) Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site. Neurobiol Dis 10: 128-138.
22. Prudencio M, Hart PJ, Borchelt DR, Andersen PM, (2009) Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease. Hum Mol Genet 18: 3217-3226.
23. Deng HX, Shi Y, Furukawa Y, Zhai H, Fu R, et al. (2006) Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria. Proc Natl Acad Sci U S A 103: 7142-7147.
24. Jonsson PA, Graffmo KS, Andersen PM, Brannstrom T, Lindberg M, et al. (2006) Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models. Brain 129: 451-464.
25. Wang J, Xu G, Borchelt DR, (2006) Mapping superoxide dismutase 1 domains of non-native interaction: roles of intra- and intermolecular disulfide bonding in aggregation. J Neurochem 96: 1277-1288.
26. Furukawa Y, Kaneko K, Yamanaka K, O'Halloran TV, Nukina N, (2008) Complete loss of post-translational modifications triggers fibrillar aggregation of SOD1 in the familial form of amyotrophic lateral sclerosis. J Biol Chem 283: 24167-24176.
27. Banci L, Bertini I, Durazo A, Girotto S, Gralla EB, et al. (2007) Metal-free superoxide dismutase forms soluble oligomers under physiological conditions: a possible general mechanism for familial ALS. Proc Natl Acad Sci U S A 104: 11263-11267.
28. Karch CM, Borchelt DR, (2008) A limited role for disulfide cross-linking in the aggregation of mutant SOD1 linked to familial amyotrophic lateral sclerosis. J Biol Chem 283: 13528-13537.
29. Watanabe M, Dykes-Hoberg M, Culotta VC, Price DL, Wong PC, et al. (2001) Histological Evidence of Protein Aggregation in Mutant SOD1 Transgenic Mice and in Amyotrophic Lateral Sclerosis Neural Tissues. Neurobiol Dis 8: 933-941.
30. Prudencio M, Borchelt DR, (2011) Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded states. Mol Neurodegener 6: 77.
31. Corcoran LJ, Mitchison TJ, Liu Q, (2004) A novel action of histone deacetylase inhibitors in a protein aggresome disease model. Curr Biol 14: 488-492.
32. Turner BJ, Atkin JD, Farg MA, Zang DW, Rembach A, et al. (2005) Impaired extracellular secretion of mutant superoxide dismutase 1 associates with neurotoxicity in familial amyotrophic lateral sclerosis. J Neurosci 25: 108-117.
33. Matsumoto G, Stojanovic A, Holmberg CI, Kim S, Morimoto RI, (2005) Structural properties and neuronal toxicity of amyotrophic lateral sclerosis-associated Cu/Zn superoxide dismutase 1 aggregates. J Cell Biol 171: 75-85.
34. Zhang F, Zhu H, (2006) Intracellular conformational alterations of mutant SOD1 and the implications for fALS-associated SOD1 mutant induced motor neuron cell death. Biochim Biophys Acta 1760: 404-414.
35. Fei E, Jia N, Yan M, Ying Z, Sun Q, et al. (2006) SUMO-1 modification increases human SOD1 stability and aggregation. Biochem Biophys Res Commun 347: 406-412.
36. Urushitani M, Ezzi SA, Matsuo A, Tooyama I, Julien JP, (2008) The endoplasmic reticulum-Golgi pathway is a target for translocation and aggregation of mutant superoxide dismutase linked to ALS. FASEB J 22: 2476-2487.
37. Witan H, Gorlovoy P, Kaya AM, Koziollek-Drechsler I, Neumann H, et al. (2009) Wild-type Cu/Zn superoxide dismutase (SOD1) does not facilitate, but impedes the formation of protein aggregates of amyotrophic lateral sclerosis causing mutant SOD1. Neurobiol Dis 36: 331-342.
38. Prudencio M, Durazo A, Whitelegge JP, Borchelt DR, (2009) Modulation of mutant superoxide dismutase 1 aggregation by co-expression of wild-type enzyme. J Neurochem 108: 1009-1018.
39. Karch CM, Borchelt DR, (2010) Aggregation modulating elements in mutant human superoxide dismutase 1. Arch Biochem Biophys 503: 175-182.
40. Cozzolino M, Amori I, Pesaresi MG, Ferri A, Nencini M, et al. (2008) Cysteine 111 affects aggregation and cytotoxicity of mutant Cu,Zn-superoxide dismutase associated with familial amyotrophic lateral sclerosis. J Biol Chem 283: 866-874.
41. Wang J, Slunt H, Gonzales V, Fromholt D, Coonfield M, et al. (2003) Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature. Hum Mol Genet 12: 2753-2764.
42. Wang J, Xu G, Slunt HH, Gonzales V, Coonfield M, et al. (2005) Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA. Neurobiol Dis 20: 943-952.
43. Karch CM, Prudencio M, Winkler DD, Hart PJ, Borchelt DR, (2009) Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS. Proc Natl Acad Sci U S A 106: 7774-7779.
44. Karch CM, Borchelt DR, (2010) An examination of alpha B-crystallin as a modifier of SOD1 aggregate pathology and toxicity in models of familial amyotrophic lateral sclerosis. J Neurochem 113: 1092-1100.
45. Prudencio M, Durazo A, Whitelegge JP, Borchelt DR, (2010) An examination of wild-type SOD1 in modulating the toxicity and aggregation of ALS-associated mutant SOD1. Hum Mol Genet 19: 4774-4789.